BioLineRx BLRX
NASDAQ BLRX
$2.36 -0.07 (-2.88%)
As of: Sep 29, 2026 · 3:07 PM EDT

BioLineRx (BLRX) Short term Debt (2011 - 2026)

Updated

BioLineRx's Short term Debt was $4.48 million in the quarter ended Jun 30, 2026, unchanged from $4.48 million a year earlier and unchanged from the prior quarter.

Analysis

BioLineRx (BLRX) Short term Debt (2011 - 2026) Analysis & Trends

From the quarter ended Sep 30, 2011 onward, BioLineRx has reported Short term Debt for 45 quarters.

  • Short term Debt shows a five-year compound annual growth rate of 7.7% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Short term Debt was $4.48 million in the year ended Dec 31, 2024 (+42.4%), $3.15 million in the year ended Dec 31, 2023 (+104.0%), $1.54 million in the year ended Dec 31, 2022 (-44.1%) and $2.76 million in the year ended Dec 31, 2021 (-10.8%).
  • Quarterly Short term Debt has moved between $802,000 (the quarter ended Sep 30, 2022) and $10.66 million (the quarter ended Jun 30, 2024) over five years.
  • Compared with a year earlier, Short term Debt was higher in three of the last eight quarters, with growth averaging 21.5%.
  • The best year-over-year quarter for Short term Debt over five years was the quarter ended Sep 30, 2023 (growth of 283.8%); the worst was the quarter ended Sep 30, 2022 (a decline of 77.6%).
  • Per Business Quant data, BLRX's Short term Debt in the three quarters before the quarter ended Jun 30, 2026 was $4.48 million (quarter ended Mar 31, 2026), $4.48 million (quarter ended Dec 31, 2025) and $4.48 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 BioLineRx 6.34 Bn 6.35 Bn 235,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.48 Mn
Mar 31, 2026 4.48 Mn
Dec 31, 2025 4.48 Mn
Sep 30, 2025 4.48 Mn
Jun 30, 2025 4.48 Mn
Mar 31, 2025 4.68 Mn
Dec 31, 2024 4.48 Mn
Sep 30, 2024 9.82 Mn
Jun 30, 2024 10.66 Mn
Mar 31, 2024 3.68 Mn
Dec 31, 2023 3.15 Mn
Sep 30, 2023 3.08 Mn
Jun 30, 2023 3.08 Mn
Mar 31, 2023 2.56 Mn
Dec 31, 2022 1.54 Mn
Sep 30, 2022 802,000.00
Jun 30, 2022 1.01 Mn
Mar 31, 2022 1.90 Mn
Dec 31, 2021 2.76 Mn
Sep 30, 2021 3.58 Mn
API Access

BioLineRx Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=BLRX&period=max&api_key=YOUR_API_KEY